Food and Drug Administration (FDA) in June 2019 under the brand name Vyleesi for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women
These findings imply that BPC 157 may support intracellular signaling through post-translational modification rather than protein synthesis
BUILT AROUND YOUR MEDICATION GlowBack supports more than 30 GLP-1 and related medications, including: Semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide, and lixisenatide Ozempic, Wegovy injection and pill, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza, Trulicity, Byetta, Bydureon, and Adlyxin Foundayo, orforglipron, compounded semaglutide, compounded tirzepatide, oral GLP-1 options, and custom medications YOUR DAILY GLP-1 DASHBOARD See what matters today without digging through menus: Current weight, goal weight, pounds to goal, and estimated goal date Your next dose, dosage, date and time, injection site, and countdown Quick logging for shots, food, water, weight, progress photos, and side effects At-a-glance protein, fiber, and water progress DOSE TRACKER AND MEDICATION LEVELS Log injections or pills and keep your routine organized
University of Cincinnati gets $1.1M for AI physician training January 30, 2026 The University of Cincinnati College of Medicine has received a four-year, $1.1 million grant to explore using artificial intelligence and personalized learning to improve physician education.
Applicable People: Dry, oily and mixed skin can be used, and sensitive skin should be used with caution
